Dear Editor,

The severity of acute hypoxemic respiratory failure (AHRF) in Coronavirus Disease 2019 (COVID-19) correlates poorly with lung weight and lung mechanics, leading to the proposal of phenotypes that may be associated with similar degree of hypoxaemia but different lung volume, weight, and compliance \[[@CR1]\]. The alteration of the pulmonary vascular tone and immune thrombosis of the alveolar capillaries \[[@CR2]\] may account for these pathophysiological characteristics and for the high physiological dead space observed in these patients.

To describe estimated indices of physiological dead space---and their association with respiratory mechanics, severity of hypoxaemia, biomarkers, and outcomes---we performed a retrospective analysis of adult patients with COVID-19 respiratory failure requiring mechanical ventilation in four medical Intensive Care Units (ICU) within Guy's and St Thomas' NHS Trust---London, UK (Ethics reference: 10,796).

We used the recorded values at the time of worst PaO~2~/FiO~2~ observed on the day of critical care admission. Continuous variables were compared using Mann--Whitney U test. This cohort included 213 patients (73% males), mean (95%CI) age 56 (54--57) years, and PaO~2~/FiO~2~ 128 (121--135) mmHg. When subdivided in four groups based on cut-off PaO~2~/FiO~2~ of 150 mmHg and compliance of 40 mL/cmH~2~O; 72% (*n* = 154) had PaO~2~/FiO~2~ \< 150 mmHg, of these, 112 (73%, or 53% of the overall cohort) had compliance \< 40 mL/cmH~2~O (eTable 1). The mean (95%CI) estimated physiological dead space fraction \[[@CR3]\] was high in the entire cohort at 0.53 (0.51--0.56).

ICU outcome was available for 193 patients, where estimated physiological dead space fraction was higher in non-survivors \[median (IQR), 0.57 (0.46--0.65) vs. 0.5 (0.4--0.64); *p* = 0.03\]. All estimates of physiological dead space increased with the degree of hypoxaemia, but not with the reduction in lung compliance (Fig. [1](#Fig1){ref-type="fig"}). Compared with patients with PaO~2~/FiO~2~ \> 150 mmHg, patients with PaO~2~/FiO~2~ \< 150 mmHg had higher estimated physiological dead space fraction \[0.55 (0.52--0.57) vs. 0.5 (0.47--0.53); *p* = 0.036) (Fig. [1](#Fig1){ref-type="fig"}A), mean (95%CI) corrected minute volume \[[@CR4]\] \[9.3(8.8--9.7) vs. 8.2 (7.6--8.8) L/min; *p* = 0.004\] (Fig. [1](#Fig1){ref-type="fig"}B), and ventilatory ratio \[[@CR5]\] \[1.43 (1.37--1.5) vs. 1.29 (1.2--1.38); *p* = 0.001\] (Fig. [1](#Fig1){ref-type="fig"}C). Although patients with compliance \< 40 mL/cmH~2~O had a higher corrected minute volume \[[@CR4]\] \[9.4 (8.8--10) vs. 8.8 (8.4--9.3) L/min; *p* = 0.023\] (Fig. [1](#Fig1){ref-type="fig"}C), there was no difference in the two compliance groups in estimated physiological dead space fraction \[0.55 (0.48--0.56) vs. 0.54 (0.52--0.56); *p* = 0.72\] (Fig. [1](#Fig1){ref-type="fig"}A) and ventilatory ratio \[[@CR5]\] 1.4 (1.3--1.5) vs. 1.4 (1.33--1.46); *p* = 0.76) (Fig. [1](#Fig1){ref-type="fig"}B).Fig. 1Distributions of dead space indices in the groups of compliance and PaO~2~/FiO~2~. (**A**): Physiological dead space fraction; (**B**): ventilatory ratio; (**C**): corrected minute ventilation

Physiological dead space correlated with hypoxaemia, but it was dissociated from alterations in lung mechanics in COVID-19 ventilated patients. Immuno-thrombosis is a mechanism that may explain both the increase in physiological dead space and hypoxaemia. Interestingly, we found that the highest median (IQR) levels of D-Dimers \[2.1 (1--7) mg/L\]; ferritin \[1,627 (914--2555) ug/L\], CRP \[219.5 (147.25--324) mg/L\], and troponin \[23 (12--62) ng/L\] were seen in patients with PaO~2~/FiO~2~ \< 150 mmHg, but relatively preserved compliance (\> 40 mL/cmH~2~O). However, these values were statistically similar to the ones recorded in the other groups.

In conclusion, these data suggest that increased physiological dead space is a characteristic of patients with COVID-19 AHRF, with no relation with compliance of the respiratory system. Given that both PaO~2~/FiO~2~ and physiological dead space are worse in non-survivors, it is unclear if dead space is independently associated with mortality or if its effect on outcome is mediated through hypoxaemia.
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